Description
KLOW 50mg/10mg/10mg/5mg
Product Usage
Klow Blend (GHK-CU/BPC157/TB500/KPV) IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.
Introduction
Klow 80 Blend is a multi-component research compound combining four structurally distinct peptides — GHK-Cu, BPC-157, TB-500, and KPV — within a single formulation. Each constituent peptide engages distinct molecular targets and intracellular signaling pathways. The combination provides researchers with a tool for investigating the coordinated or independent contributions of these pathways to cellular and tissue-level processes in in vitro and preclinical model systems. Note: This compound is intended strictly for laboratory research and experimental use. It is not approved for human or veterinary administration.
GHK-Cu — Copper-Binding Tripeptide
GHK-Cu (Glycyl-L-Histidyl-L-Lysine : Copper) is an endogenous tripeptide-copper complex first isolated from human plasma. It has been extensively characterized in research settings for its interactions with the extracellular matrix (ECM) and its influence on fibroblast gene expression. Documented areas of in vitro and preclinical research interest include:
- Collagen and glycosaminoglycan synthesis modulation in fibroblast culture models
- Matrix metalloproteinase (MMP) activity and ECM remodeling studies
- Gene expression profiling: GHK-Cu has been shown in studies to modulate hundreds of human genes associated with oxidative stress response, proteasome function, and immune regulation
- Hair follicle dermal papilla cell studies examining proliferative and morphogenic signaling
- Copper chaperone activity and intracellular copper transport research
BPC-157 — Synthetic Body Protection Compound
BPC-157 is a synthetic pentadecapeptide derived from a region of human gastric juice protein. It has been widely studied in preclinical models for its cytoprotective and angiogenic properties, with a substantial body of peer-reviewed literature examining its effects at the cellular and organ-system levels. Documented areas of preclinical research interest include:
- Nitric oxide (NO) signaling: BPC-157 has demonstrated modulation of eNOS expression and NO production in endothelial cell models
- Angiogenesis assays: studies have documented VEGF pathway interactions and capillary formation responses in in vitro models
- Gastrointestinal mucosal cell models: cytoprotective effects on gastric and intestinal epithelial cell lines under oxidative or inflammatory challenge
- Tendon and ligament fibroblast studies examining TGF-β and growth factor receptor signaling
- Neurotrophic signaling pathways in neuronal cell culture models
TB-500 — Synthetic Thymosin Beta-4 Analogue
TB-500 is a synthetic peptide corresponding to the actin-binding domain of Thymosin Beta-4 (Tβ4), a 43-amino acid protein involved in the regulation of actin polymerization. TB-500 retains the core functional sequence LKKTETQ responsible for Tβ4’s primary biological activities in cell culture systems. Documented areas of research interest include:
- Actin dynamics: Tβ4 and its analogues are characterized tools in studies of G-actin sequestration, lamellipodia formation, and cytoskeletal reorganization
- Cell migration assays: TB-500 is used in scratch assay and Transwell models to examine directional cell motility and chemotactic responses
- Stem and progenitor cell mobilization signaling in preclinical hematopoietic and cardiac models
- Integrin-linked kinase (ILK) and PI3K/Akt pathway modulation studies
- Extracellular matrix interaction studies in dermal fibroblast and cardiomyocyte lines
KPV — C-Terminal Tripeptide of α-MSH
KPV (Lysyl-Proline-Valine) is the C-terminal tripeptide of alpha-melanocyte-stimulating hormone (α-MSH). This fragment retains several of the parent molecule’s documented immunomodulatory properties and is of active research interest given its ability to penetrate cell membranes and interact with intracellular inflammatory signaling components without requiring melanocortin receptor binding. Documented areas of in vitro and preclinical research interest include:
- NF-κB pathway studies: KPV has been shown to inhibit IκB degradation and nuclear translocation of NF-κB subunits in stimulated macrophage and epithelial cell models
- Pro-inflammatory cytokine modulation: research has documented KPV effects on IL-1β, IL-6, TNF-α, and IL-8 expression in LPS-challenged cell lines
- Intestinal epithelial permeability studies examining tight junction protein regulation under inflammatory conditions
- Antimicrobial peptide research: KPV has demonstrated activity against select gram-positive organisms in bacterial culture studies
- Melanocortin-independent intracellular signaling pathway characterization
| Peptide | Classification | Primary Research Focus |
| GHK-Cu | Copper-binding tripeptide | Extracellular matrix remodeling, fibroblast activation, oxidative stress modulation |
| BPC-157 | Synthetic pentadecapeptide (body protection compound) | Angiogenesis pathways, cytoprotective mechanisms, nitric oxide signaling |
| TB-500 | Synthetic analogue of Thymosin Beta-4 | Actin cytoskeletal dynamics, cell migration assays, extracellular matrix interaction |
| KPV | C-terminal tripeptide of α-MSH | NF-κB pathway modulation, cytokine regulation, microbial response in model systems |
Potential Research Applications
The multi-target composition of Klow Blend makes it a candidate for studies examining cross-pathway interactions that a single-peptide formulation cannot address. Researchers may find this compound of interest in the following investigative contexts:
Inflammatory Signaling Cross-Talk
KPV’s NF-κB modulation and BPC-157’s NO pathway interactions can be studied in parallel to characterize inflammatory signal integration in primary cell and organoid models. Simultaneous activation and suppression of distinct pro-inflammatory nodes allows for dose-response profiling of synergistic or antagonistic relationships.
Extracellular Matrix Remodeling Studies
GHK-Cu and TB-500 engage complementary arms of ECM regulation — copper-mediated collagen synthesis on one hand, and actin cytoskeletal reorganization facilitating cellular matrix remodeling on the other. Combined, they present an opportunity to model coordinated matrix-rebuilding activity in fibroblast or mesenchymal stem cell systems.
Angiogenesis and Vascular Cell Biology
BPC-157’s VEGF and NO pathway interactions can be studied alongside TB-500’s cell migration effects in endothelial tube formation assays, providing a multi-factor model of neovascularization signaling relevant to ischemia, organogenesis, and tumor biology research.
Epithelial Barrier and Mucosal Biology
BPC-157 cytoprotective activity in gastrointestinal epithelial models and KPV’s documented effects on intestinal tight junction proteins make this blend applicable to intestinal barrier function research, including studies of inflammatory bowel models and mucosal immune regulation.
Multi-Pathway Gene Expression Profiling
Given the broad gene expression modulatory activity attributed to GHK-Cu (documented across >4,000 human genes in array studies), combined with the signaling activities of the other three peptides, Klow Blend may serve as a useful tool in systems biology or transcriptomic studies investigating convergent cellular stress-response networks.
Handling & Storage Specifications
| Parameter | Specification |
| Long-Term Storage | −20°C, sealed, protected from light |
| Working Solution | Sterile aqueous buffer or DMSO (peptide-grade); reconstitute per standard laboratory protocols |
| Stability | Lyophilized: 24 months under recommended conditions; reconstituted: use within 7 days or aliquot and re-freeze |
| Solubility | Water-soluble under physiological pH; refer to individual peptide datasheets for solubility optimization |
| Purity | ≥98% by HPLC (batch certificate of analysis provided) |
| Handling | Avoid repeated freeze-thaw cycles. Use appropriate PPE per institutional biosafety guidelines |





Reviews
There are no reviews yet.